Price to Operating Profit (P/OP)
since 2005
Paying user area
Try for free
UnitedHealth Group Inc. pages available for free this week:
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Common-Size Income Statement
- Analysis of Profitability Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Price to FCFE (P/FCFE)
- Capital Asset Pricing Model (CAPM)
- Selected Financial Data since 2005
- Operating Profit Margin since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to UnitedHealth Group Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
UnitedHealth Group Inc., P/OP, long-term trends, calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Earnings from operations1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2024 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 15, 2022 | = | ÷ | = | ÷ | |||||||
| Mar 1, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 14, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 12, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 13, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 8, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 9, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 10, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 12, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 7, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 9, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 10, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 10, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 11, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2008 | = | ÷ | = | ÷ | |||||||
| Mar 6, 2007 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of UnitedHealth Group Inc. Annual Report.
- Share Price Trend
- The share price exhibited volatility in the early years, declining from $58.89 in 2006 to a low of $28.55 in 2009. From 2009 onwards, there was a notable upward trajectory, with the share price increasing steadily and peaking at $498.28 in 2024 before declining slightly to $468.56 in 2025. This overall growth indicates strong market confidence and positive valuation over the long term despite short-term fluctuations.
- Operating Profit Per Share (OPPS) Trend
- The operating profit per share showed a generally consistent upward trend from $3.96 in 2006 to $35.3 in 2025. There was a brief dip in 2009 corresponding with the share price decline, potentially reflecting economic conditions impacting profitability. However, after 2009, the OPPS increased steadily, suggesting improving operational efficiency and profitability over time.
- Price to Operating Profit (P/OP) Ratio Analysis
- The price-to-operating profit ratio decreased from 14.87 in 2006 to a low of 5.9–6.59 in the period 2009–2011, reflecting undervaluation or improved earnings relative to price during that timeframe. Following this, the ratio generally increased, reaching 18.77 in 2022, indicating that the share price grew at a faster pace than operating profits during those years. More recently, the P/OP ratio moderated to approximately 13.27 in 2025, suggesting a slight revaluation or alignment between price and profit levels.
- Summary of Key Insights
- The data reveals an initial period of decline in both share price and operating profit per share during the late 2000s, likely influenced by macroeconomic factors. Subsequently, both metrics demonstrated sustained growth. The share price rose more sharply than earnings, as reflected in the P/OP ratio movements, indicating phases of heightened investor optimism. The alignment of the P/OP ratio toward the end of the period suggests a more balanced market valuation relative to operating profits.
Comparison to Competitors
UnitedHealth Group Inc., P/OP, long-term trends, comparison to competitors
| UnitedHealth Group Inc. | Abbott Laboratories | CVS Health Corp. | Intuitive Surgical Inc. | Medtronic PLC | |
|---|---|---|---|---|---|
| Feb 27, 2025 | |||||
| Feb 28, 2024 | |||||
| Feb 24, 2023 | |||||
| Feb 15, 2022 | |||||
| Mar 1, 2021 | |||||
| Feb 14, 2020 | |||||
| Feb 12, 2019 | |||||
| Feb 13, 2018 | |||||
| Feb 8, 2017 | |||||
| Feb 9, 2016 | |||||
| Feb 10, 2015 | |||||
| Feb 12, 2014 | |||||
| Feb 7, 2013 | |||||
| Feb 9, 2012 | |||||
| Feb 10, 2011 | |||||
| Feb 10, 2010 | |||||
| Feb 11, 2009 | |||||
| Feb 21, 2008 | |||||
| Mar 6, 2007 | |||||
| Feb 24, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).